Jun Zhu

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)

Shiping Liu, Yi Zhang, S. Yoo, 2022, BMC medical genomics.

NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer

Brian H. Lee, M. Carrington, M. Skobe, 2022, bioRxiv.

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.

M. Skobe, R. Sebra, M. Galsky, 2022, Cancer cell.

Lessons learned from expanded reproductive carrier screening in self‐reported Ashkenazi, Sephardi, and Mizrahi Jewish patients

Mitchell W Dillon, E. Schadt, L. Edelmann, 2019, Molecular genetics & genomic medicine.

A Bayesian model for identifying cancer subtypes from paired methylation profiles

S. Leung, Xiaodan Fan, Yetian Fan, 2022, Briefings Bioinform..

Viral integration drives multifocal HCC during the occult HBV infection

K. Kristiansen, Kui Wu, A. Laurence, 2019, Journal of Experimental & Clinical Cancer Research.

Detecting virus-specific effects on post-infection temporal gene expression

Quan Chen, Jun Zhu, Quan Chen, 2019, BMC Bioinformatics.

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

R. Sebra, M. Galsky, T. Dorff, 2023, Nature Medicine.